Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.570
-0.040 (-1.53%)
Nov 4, 2024, 4:00 PM EST - Market closed
Nautilus Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -70.21 | -63.68 | -57.92 | -50.32 | -15.62 | -9.62 |
| Depreciation & Amortization | 6.39 | 5.71 | 3.42 | 2.84 | 2.35 | 0.55 |
| Loss (Gain) From Sale of Assets | - | - | - | 0.14 | 0.01 | - |
| Loss (Gain) From Sale of Investments | -2.8 | -2.66 | -0.89 | 0.18 | 0.28 | -0.22 |
| Stock-Based Compensation | 12.65 | 12.14 | 10.38 | 7.93 | 0.37 | 0.11 |
| Change in Accounts Payable | 0.34 | 0.39 | -0.56 | 1.26 | 0.12 | 0.07 |
| Change in Other Net Operating Assets | -5.11 | -3.61 | -0.23 | -1.28 | -1.51 | -0.55 |
| Operating Cash Flow | -58.74 | -51.71 | -45.81 | -39.24 | -14 | -9.66 |
| Capital Expenditures | -2.28 | -2.44 | -2.32 | -2.27 | -0.92 | -0.93 |
| Investment in Securities | -9.64 | -41.29 | -23.42 | -136.7 | -24.36 | 4.98 |
| Investing Cash Flow | -11.92 | -43.74 | -25.74 | -138.96 | -25.28 | 4.05 |
| Issuance of Common Stock | 0.96 | 0.37 | 0.56 | 335.58 | 0.04 | 0.04 |
| Other Financing Activities | - | - | - | -8.13 | - | - |
| Financing Cash Flow | 0.96 | 0.37 | 0.56 | 327.45 | 75.9 | 0.04 |
| Net Cash Flow | -69.7 | -95.08 | -70.98 | 149.24 | 36.62 | -5.58 |
| Free Cash Flow | -61.02 | -54.15 | -48.13 | -41.51 | -14.92 | -10.59 |
| Free Cash Flow Per Share | -0.49 | -0.43 | -0.39 | -0.49 | -0.51 | -1.75 |
| Levered Free Cash Flow | -35 | -32.09 | -27.58 | -22.33 | -7.61 | - |
| Unlevered Free Cash Flow | -35 | -32.09 | -27.58 | -22.33 | -7.61 | - |
| Change in Net Working Capital | 0.82 | -0.1 | -0.71 | -0.73 | -0.44 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.